予防 (JP Patent Analysis Report)
The Technical Field "予防" had 187 patent application filings in the most recent period (2023-01-01 to 2023-04-30). This is a significantly decreased of -854 filings (-82.0%) over 1,041 they had in the same period of the previous year (2022-01-01 to 2022-04-30).
The highest number of filings in 2017 with 4,377 cases, and their lowest number in 2023 with 336 cases.
The mean of the number of filings over the last 5 years (2019 to 2024, 15,383 cases in total) is 2,564, and the median is 3,447. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 2,564 patents |
| Std Dev | 1,710 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 336 cases | -89.6 % |
| 2022 year | 3,231 cases | -14.11 % |
| 2021 year | 3,762 cases | +2.70 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 予防 for the period of the last 10 years (2015-01-01 to 2024-12-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 予防, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
予防, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 予防 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 31,989 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
予防
Related Patent Analysis Report
A patent aanlysis report on the following synonyms was found in the technical term "予防".
- 予防 (Main page / Including the following synonyms)
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 予防 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 10 cases, followed by 小野薬品工業株式会社 with 3 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 10 cases |
| 小野薬品工業株式会社 | 3 cases |
| 田辺三菱製薬株式会社 | 3 cases |
| 武田薬品工業株式会社 | 1 cases |
| エフホフマン-ラロシュアーゲー | 1 cases |
| ノバルティスアーゲー | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Comparing the number of applications of each company, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 380 cases, followed by ノバルティスアーゲー with 294 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 380 cases |
| ノバルティスアーゲー | 294 cases |
| ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング | 200 cases |
| 武田薬品工業株式会社 | 194 cases |
| 花王株式会社 | 160 cases |
| 小野薬品工業株式会社 | 99 cases |
| サノフイ | 72 cases |
| 田辺三菱製薬株式会社 | 60 cases |
| メルク・シャープ・アンド・ドーム・コーポレーション | 55 cases |
| アステラス製薬株式会社 | 46 cases |
| メルク・シャープ・エンド・ドーム・コーポレイション | 2 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 予防 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 10 cases, followed by 武田薬品工業株式会社 with 1 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 10 cases |
| 武田薬品工業株式会社 | 1 cases |
| エフホフマン-ラロシュアーゲー | 1 cases |
| ノバルティスアーゲー | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Among the top coapplicants, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 380 cases, followed by ノバルティスアーゲー with 294 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 380 cases |
| ノバルティスアーゲー | 294 cases |
| ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング | 200 cases |
| 武田薬品工業株式会社 | 194 cases |
| 花王株式会社 | 160 cases |
| アステラス製薬株式会社 | 46 cases |
| メルク・シャープ・エンド・ドーム・コーポレイション | 2 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 予防’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 予防’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with 武田薬品工業株式会社
予防 filed 194 joint applications with 武田薬品工業株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 62 cases in total) is 10.3, and the median is 7.0. The coefficient of variation (standard deviation/mean) is 1.1, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 37 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 10.3 patents |
| Std Dev | 11.1 |
| COV | 1.1 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -66.7 % |
| 2022 year | 3 cases | -72.7 % |
| 2021 year | 11 cases | -26.67 % |
Trends in filing of joint patent applications with エフホフマン-ラロシュアーゲー
予防 filed 380 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 178 cases in total) is 29.7, and the median is 36.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 60 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 29.7 patents |
| Std Dev | 21.9 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -96.9 % |
| 2022 year | 32 cases | -33.3 % |
| 2021 year | 48 cases | +17.07 % |
Trends in filing of joint patent applications with ノバルティスアーゲー
予防 filed 294 joint applications with ノバルティスアーゲー for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 100 cases in total) is 16.7, and the median is 18.5. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 57 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 16.7 patents |
| Std Dev | 12.8 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -92.9 % |
| 2022 year | 14 cases | -39.1 % |
| 2021 year | 23 cases | -20.69 % |
Trends in filing of joint patent applications with 花王株式会社
予防 filed 160 joint applications with 花王株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 74 cases in total) is 12.3, and the median is 10.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2016 with 26 cases, and their lowest number in 2023 with 10 cases.
| Index | Value |
|---|---|
| Average | 12.3 patents |
| Std Dev | 7.9 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 10 cases | -61.5 % |
| 2022 year | 26 cases | +52.9 % |
| 2021 year | 17 cases | +70.0 % |
Trends in filing of joint patent applications with ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング
予防 filed 200 joint applications with ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 100 cases in total) is 16.7, and the median is 20.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2021 with 38 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 16.7 patents |
| Std Dev | 13.3 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 22 cases | -42.1 % |
| 2021 year | 38 cases | +90.0 % |
| 2020 year | 20 cases | 0 |
Information on important patents (JP)
The following shows JP patents held by 予防 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 予防’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 予防 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 20 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.4 times. The most recently Invalidation Trial patent is 特許4001199 "ヒドロピリジン誘導体酸付加塩" (Invalidation Trial day 2024-10-10) , next is 特許4029974 "ヒドロピリジン誘導体酸付加塩を含有する医薬" (Invalidation Trial day 2024-09-20) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許4001199 | ヒドロピリジン誘導体酸付加塩 | 2024-10-10 |
| 2 | 特許4029974 | ヒドロピリジン誘導体酸付加塩を含有する医薬 | 2024-09-20 |
| 3 | 特許6995822 | ＤＰＰ ＩＶインヒビターの使用 | 2024-06-25 |
| 4 | 特許7174020 | 経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療 | 2024-05-31 |
| 5 | 特許7258832 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2024-05-08 |
| 6 | 特許6811203 | 経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療 | 2024-04-24 |
| 7 | 特許6480887 | メトホルミン治療に不適切な患者における糖尿病の治療 | 2024-03-22 |
| 8 | 特許6556767 | ＤＰＰ−４阻害剤（リナグリプチン）を任意で他の抗糖尿病薬と組み合わせて含む抗糖尿病薬 | 2024-03-19 |
| 9 | 特許6290627 | メトホルミン治療に不適切な患者における糖尿病の治療 | 2024-02-29 |
| 10 | 特許6262023 | 経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療 | 2024-01-31 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 13 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.2. The most invalidation trial patent is 特許5906333 "プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質" (2 times) , and the next most invalidation trial patent is 特許6198346 "１回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤" (2 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許5906333 | プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質 | 2 times |
| 2 | 特許6198346 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 2 times |
| 3 | 特許6480887 | メトホルミン治療に不適切な患者における糖尿病の治療 | 2 times |
| 4 | 特許6274634 | 骨粗鬆症治療剤ないし予防剤 | 1 times |
| 5 | 特許6554730 | ビフィドバクテリウム・ロンガム及び海馬ＢＤＮＦ発現 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 21 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7492459 "加齢に関連する状態の診断及び治療のための組成物及び方法" (Opposition day 2024-11-27) , next is 特許7473261 "女性特有の嗜好変化に伴う広告配信システムおよび広告配信方法" (Opposition day 2024-10-22) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7492459 | 加齢に関連する状態の診断及び治療のための組成物及び方法 | 2024-11-27 |
| 2 | 特許7473261 | 女性特有の嗜好変化に伴う広告配信システムおよび広告配信方法 | 2024-10-22 |
| 3 | 特許7425603 | 医薬組成物 | 2024-07-29 |
| 4 | 特許7373183 | 歯科診療用の診療支援システムおよび診療支援装置 | 2024-04-26 |
| 5 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 6 | 特許7282155 | 頭皮用外用組成物 | 2023-11-24 |
| 7 | 特許7308329 | ＧＡＢＡを有効成分とするサルコペニア予防または改善剤 | 2023-10-26 |
| 8 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
| 9 | 特許7237544 | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 | 2023-09-11 |
| 10 | 特許7182765 | 月経に伴う身体的及び／又は精神的不快症状の改善システム | 2023-06-02 |
Protested cases
List of latest Protested patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 107 patents Protest from third parties. The average number of Protest is 1.6 times. The most recently Protest patent is 特開2023-100665 "栄養製品" (Protest day 2024-12-13) , next is 特表2022-509359 "生体内での最適な真皮白色脂肪組織形成を促進するための局所組成物および方法" (Protest day 2024-11-28) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2023-100665 | 栄養製品 | 2024-12-13 |
| 2 | 特表2022-509359 | 生体内での最適な真皮白色脂肪組織形成を促進するための局所組成物および方法 | 2024-11-28 |
| 3 | 特表2024-501951 | 小胞体ストレス減少用組成物 | 2024-11-05 |
| 4 | 特開2021-151223 | マイオカイン産生促進剤、筋出力増強剤、および筋芽細胞の分化促進剤 | 2024-10-18 |
| 5 | 特開2022-100719 | 認知機能における作業記憶向上用組成物 | 2024-10-17 |
| 6 | 特開2021-046394 | ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物 | 2024-10-09 |
| 7 | 特許7037667 | ＳＴＩＮＧアダプタータンパク質を活性化するホスホン酸結合を有する３’３’環状ジヌクレオチド | 2024-10-09 |
| 8 | 特表2023-546415 | ペットフード組成物 | 2024-10-02 |
| 9 | 特開2023-085454 | 低濃度アトロピン眼科用製剤の安定性を改善するための方法 | 2024-10-01 |
| 10 | 特表2023-535067 | ヒトにおける呼吸器疾患の治療及び／又は予防のためのβ－ヒドロキシブチレート及び関連化合物の投与 | 2024-09-18 |
| 11 | 特開2021-109843 | コバエ発生予防剤及びコバエ発生予防エアゾール製品 | 2024-09-13 |
| 12 | 特表2024-508454 | 局所皮膚細菌性皮膚疾患治療用組成物 | 2024-09-12 |
| 13 | 特開2022-070189 | 洗口剤用組成物 | 2024-09-11 |
| 14 | 特開2020-193227 | 外用組成物 | 2024-09-05 |
| 15 | 特表2024-504870 | 含窒素架橋複素環化合物、その調製方法及びその医薬的応用 | 2024-09-02 |
| 16 | 特表2023-505246 | 無機物および／またはビタミンならびに多糖を含む製剤、その組成物ならびに前記無機物および／またはビタミンの補充におけるその使用 | 2024-08-22 |
| 17 | 特開2021-017447 | 外用組成物 | 2024-08-21 |
| 18 | 特開2022-084805 | 植物由来原料の活性炭からミネラルを抽出する方法 | 2024-07-20 |
| 19 | 特許7598699 | 視覚機能の再活性化用眼科組成物 | 2024-07-19 |
| 20 | 特開2023-060159 | 外用組成物 | 2024-06-28 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 214 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.5. The most protest patent is 特開2020-193227 "外用組成物" (13 times) , and the next most protest patent is 特開2019-022520 "組成物" (9 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2020-193227 | 外用組成物 | 13 times |
| 2 | 特開2019-022520 | 組成物 | 9 times |
| 3 | 特開2023-060159 | 外用組成物 | 6 times |
| 4 | 特開2016-084337 | 外用組成物 | 6 times |
| 5 | 特許6934150 | 経口組成物 | 5 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 537 patents Inspection from third parties. The average number of Inspection is 2.0 times. The most recently Inspection patent is 特表2022-515920 "リファマイシン－キノリジノン結合分子及びその薬学的に許容される塩の適用" (Inspection day 2024-12-27) , next is 特開2023-060159 "外用組成物" (Inspection day 2024-12-25) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2022-515920 | リファマイシン－キノリジノン結合分子及びその薬学的に許容される塩の適用 | 2024-12-27 |
| 2 | 特開2023-060159 | 外用組成物 | 2024-12-25 |
| 3 | 特表2020-533396 | ＧＳＫ１２７８８６３の結晶形及びその製造方法並びに医薬用途 | 2024-12-19 |
| 4 | 特開2023-065454 | １５－オキソ－ＥＰＡまたは１５－オキソ－ＤＧＬＡを含む組成物、ならびにその作製及び使用方法 | 2024-12-18 |
| 5 | 特表2021-525549 | 腫瘍特異的ネオ抗原およびその使用方法 | 2024-12-04 |
| 6 | 特表2024-515115 | 台風に備えたコンテナクレーン用自動化安全固縛システム | 2024-12-03 |
| 7 | 特表2021-532776 | 造血細胞の遺伝子改変のための方法 | 2024-11-29 |
| 8 | 特許7600282 | ５′－アデノシン二リン酸リボース（ＡＤＰＲ）の使用方法 | 2024-11-27 |
| 9 | 特表2022-516318 | カプセル化ポリヌクレオチド及び使用方法 | 2024-11-22 |
| 10 | 特表2022-516199 | ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物 | 2024-11-21 |
| 11 | 特表2022-514116 | 新規な癌抗原及び方法 | 2024-11-21 |
| 12 | 特許6231007 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 13 | 特許7250736 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 14 | 特開2022-091866 | 針刺入装置及び薬物アプリケーター | 2024-11-15 |
| 15 | 特許6378087 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 16 | 特開2017-195889 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 17 | 特開2022-100719 | 認知機能における作業記憶向上用組成物 | 2024-11-13 |
| 18 | 特表2022-513077 | クロストリジウム・ディフィシル多成分ワクチン | 2024-11-12 |
| 19 | 特許7513305 | ３次元培養された幹細胞から細胞外小胞体を製造する方法 | 2024-11-12 |
| 20 | 特表2024-501951 | 小胞体ストレス減少用組成物 | 2024-11-12 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 933 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.4. The most inspection patent is 特許6320473 "アロＮＫＴ細胞を用いた免疫療法およびそのためのＴ細胞抗原受容体（ＴＣＲ）遺伝子のα鎖領域が均一なＶα−Ｊαに再構成されている細胞および該細胞由来ＮＫＴ細胞のバンキング" (48 times) , and the next most inspection patent is 特許6198346 "１回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤" (18 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6320473 | アロＮＫＴ細胞を用いた免疫療法およびそのためのＴ細胞抗原受容体（ＴＣＲ）遺伝子のα鎖領域が均一なＶα−Ｊαに再構成されている細胞および該細胞由来ＮＫＴ細胞のバンキング | 48 times |
| 2 | 特許6198346 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 18 times |
| 3 | 特許6150846 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 15 times |
| 4 | 特許6934150 | 経口組成物 | 11 times |
| 5 | 特許6043008 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 11 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 4,862 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.2. The most cited patent is 特表2018-501927 "片頭痛の頭痛の防止的処置のための方法およびシステム" (45 times) , and the next most cited patent is 特許6395765 "配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化" (36 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特表2018-501927 | 片頭痛の頭痛の防止的処置のための方法およびシステム | 45 times |
| 2 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 36 times |
| 3 | 特開2019-014709 | 皮膚外用組成物 | 36 times |
| 4 | 特開2020-067939 | 感染リスク特定システム、情報端末、及び、感染リスク特定方法 | 34 times |
| 5 | 特許6855796 | 運転支援装置 | 34 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.